<SEC-DOCUMENT>0001104659-16-142983-index.html : 20160902 <SEC-HEADER>0001104659-16-142983.hdr.sgml : 20160902 <ACCEPTANCE-DATETIME>20160902163627 ACCESSION NUMBER: 0001104659-16-142983 CONFORMED SUBMISSION TYPE: 8-K/A PUBLIC DOCUMENT COUNT: 6 CONFORMED PERIOD OF REPORT: 20160722 ITEM INFORMATION: Financial Statements and Exhibits FILED AS OF DATE: 20160902 DATE AS OF CHANGE: 20160902 FILER: COMPANY DATA: COMPANY CONFORMED NAME: MADRIGAL PHARMACEUTICALS, INC. CENTRAL INDEX KEY: 0001157601 STANDARD INDUSTRIAL CLASSIFICATION: PHARMACEUTICAL PREPARATIONS [2834] IRS NUMBER: 000000000 FISCAL YEAR END: 1231 FILING VALUES: FORM TYPE: 8-K/A SEC ACT: 1934 Act SEC FILE NUMBER: 001-33277 FILM NUMBER: 161869086 BUSINESS ADDRESS: STREET 1: 500 OFFICE CENTER DRIVE, SUITE 400 CITY: FORT WASHINGTON STATE: PA ZIP: 19034 BUSINESS PHONE: 610-527-6790 MAIL ADDRESS: STREET 1: 500 OFFICE CENTER DRIVE, SUITE 400 CITY: FORT WASHINGTON STATE: PA ZIP: 19034 FORMER COMPANY: FORMER CONFORMED NAME: SYNTA PHARMACEUTICALS CORP DATE OF NAME CHANGE: 20010815 </SEC-HEADER> <DOCUMENT> <TYPE>8-K/A <SEQUENCE>1 <FILENAME>a16-17890_18ka.htm <DESCRIPTION>8-K/A <TEXT> Document 1 - file: a16-17890_18ka.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-23.1 <SEQUENCE>2 <FILENAME>a16-17890_1ex23d1.htm <DESCRIPTION>EX-23.1 <TEXT> Document 2 - file: a16-17890_1ex23d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.1 <SEQUENCE>3 <FILENAME>a16-17890_1ex99d1.htm <DESCRIPTION>EX-99.1 <TEXT> Document 3 - file: a16-17890_1ex99d1.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.2 <SEQUENCE>4 <FILENAME>a16-17890_1ex99d2.htm <DESCRIPTION>EX-99.2 <TEXT> Document 4 - file: a16-17890_1ex99d2.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.3 <SEQUENCE>5 <FILENAME>a16-17890_1ex99d3.htm <DESCRIPTION>EX-99.3 <TEXT> Document 5 - file: a16-17890_1ex99d3.htm
</DOCUMENT> <DOCUMENT> <TYPE>EX-99.4 <SEQUENCE>6 <FILENAME>a16-17890_1ex99d4.htm <DESCRIPTION>EX-99.4 <TEXT> Document 6 - file: a16-17890_1ex99d4.htm
</DOCUMENT> </SEC-DOCUMENT>